If it happens to you, its a problem. The ocular risks of GLP-1RAs While GLP-1RAs are very positive and transformative pharmaceutical agents for chronic disease management, the report states, they have been associated with exacerbation of age-related macular degeneration, progression of diabetic retinopathy, and, most seriously, NAION
Their value lies in their competitive overall cost, the flexibility of their microdosing option, and the incredible behavioral support to help users get the best long-term results
This rapid growth is placing significant pressure on insurers and employer-sponsored health plans
Microdosing GLP-1s is hardly a one-size fits all process, and its important to use a telehealth platform that offers a truly personalized plan
Given these differences in cohort characteristics, and that women appeared to experience greater WL than men with retatrutide, it may suggest that the mean WL might have been even higher with a higher proportion of women in phase 2 retatrutide trials
